| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 9.643 minutes | 33406817 |
| Predicted by Siyang using ReTip algorithm on June 8, 2022 | 8.32 minutes | 32390414 |
| Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 472.4 seconds | 40023050 |
| Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 182.0 seconds | 40023050 |
| Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 105.9 seconds | 40023050 |
| Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 160.1 seconds | 40023050 |
| RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 61.1 seconds | 40023050 |
| Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 254.8 seconds | 40023050 |
| BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 319.7 seconds | 40023050 |
| HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 912.0 seconds | 40023050 |
| UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 630.6 seconds | 40023050 |
| BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 92.1 seconds | 40023050 |
| UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 859.6 seconds | 40023050 |
| SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 207.2 seconds | 40023050 |
| RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 212.8 seconds | 40023050 |
| MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 522.8 seconds | 40023050 |
| KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 377.6 seconds | 40023050 |
| Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 221.4 seconds | 40023050 |
| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,1TMS,isomer #1 | CC(C)(COP(=O)(O)O)C(O[Si](C)(C)C)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 2927.2 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,1TMS,isomer #2 | CC(C)(COP(=O)(O)O[Si](C)(C)C)C(O)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 2975.8 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,1TMS,isomer #3 | CC(C)(COP(=O)(O)O)C(O)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C | 2962.8 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TMS,isomer #1 | CC(C)(COP(=O)(O)O[Si](C)(C)C)C(O[Si](C)(C)C)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 2885.4 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TMS,isomer #1 | CC(C)(COP(=O)(O)O[Si](C)(C)C)C(O[Si](C)(C)C)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 2885.8 | Standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TMS,isomer #1 | CC(C)(COP(=O)(O)O[Si](C)(C)C)C(O[Si](C)(C)C)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 3698.5 | Standard polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TMS,isomer #2 | CC(C)(COP(=O)(O)O)C(O[Si](C)(C)C)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C | 2934.6 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TMS,isomer #2 | CC(C)(COP(=O)(O)O)C(O[Si](C)(C)C)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C | 2921.9 | Standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TMS,isomer #2 | CC(C)(COP(=O)(O)O)C(O[Si](C)(C)C)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C | 3908.7 | Standard polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TMS,isomer #3 | CC(C)(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(O)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 2936.9 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TMS,isomer #3 | CC(C)(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(O)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 2916.3 | Standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TMS,isomer #3 | CC(C)(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(O)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 3688.5 | Standard polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TMS,isomer #4 | CC(C)(COP(=O)(O)O[Si](C)(C)C)C(O)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C | 2907.4 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TMS,isomer #4 | CC(C)(COP(=O)(O)O[Si](C)(C)C)C(O)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C | 2919.2 | Standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TMS,isomer #4 | CC(C)(COP(=O)(O)O[Si](C)(C)C)C(O)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C | 3856.0 | Standard polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,3TMS,isomer #1 | CC(C)(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(O[Si](C)(C)C)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 2862.2 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,3TMS,isomer #1 | CC(C)(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(O[Si](C)(C)C)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 2911.1 | Standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,3TMS,isomer #1 | CC(C)(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(O[Si](C)(C)C)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 3311.9 | Standard polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,3TMS,isomer #2 | CC(C)(COP(=O)(O)O[Si](C)(C)C)C(O[Si](C)(C)C)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C | 2889.9 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,3TMS,isomer #2 | CC(C)(COP(=O)(O)O[Si](C)(C)C)C(O[Si](C)(C)C)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C | 2920.5 | Standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,3TMS,isomer #2 | CC(C)(COP(=O)(O)O[Si](C)(C)C)C(O[Si](C)(C)C)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C | 3483.4 | Standard polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,3TMS,isomer #3 | CC(C)(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(O)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C | 2886.9 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,3TMS,isomer #3 | CC(C)(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(O)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C | 2938.3 | Standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,3TMS,isomer #3 | CC(C)(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(O)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C | 3499.4 | Standard polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,4TMS,isomer #1 | CC(C)(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(O[Si](C)(C)C)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C | 2882.6 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,4TMS,isomer #1 | CC(C)(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(O[Si](C)(C)C)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C | 2924.3 | Standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,4TMS,isomer #1 | CC(C)(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(O[Si](C)(C)C)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C | 3185.8 | Standard polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,1TBDMS,isomer #1 | CC(C)(COP(=O)(O)O)C(O[Si](C)(C)C(C)(C)C)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 3130.9 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,1TBDMS,isomer #2 | CC(C)(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(O)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 3194.4 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,1TBDMS,isomer #3 | CC(C)(COP(=O)(O)O)C(O)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C(C)(C)C | 3178.9 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TBDMS,isomer #1 | CC(C)(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 3310.3 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TBDMS,isomer #1 | CC(C)(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 3245.2 | Standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TBDMS,isomer #1 | CC(C)(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 3732.1 | Standard polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TBDMS,isomer #2 | CC(C)(COP(=O)(O)O)C(O[Si](C)(C)C(C)(C)C)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C(C)(C)C | 3363.1 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TBDMS,isomer #2 | CC(C)(COP(=O)(O)O)C(O[Si](C)(C)C(C)(C)C)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C(C)(C)C | 3303.7 | Standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TBDMS,isomer #2 | CC(C)(COP(=O)(O)O)C(O[Si](C)(C)C(C)(C)C)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C(C)(C)C | 3917.5 | Standard polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TBDMS,isomer #3 | CC(C)(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(O)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 3397.1 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TBDMS,isomer #3 | CC(C)(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(O)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 3247.4 | Standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TBDMS,isomer #3 | CC(C)(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(O)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 3759.1 | Standard polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TBDMS,isomer #4 | CC(C)(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(O)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C(C)(C)C | 3373.1 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TBDMS,isomer #4 | CC(C)(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(O)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C(C)(C)C | 3279.6 | Standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,2TBDMS,isomer #4 | CC(C)(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(O)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C(C)(C)C | 3900.3 | Standard polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,3TBDMS,isomer #1 | CC(C)(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 3509.3 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,3TBDMS,isomer #1 | CC(C)(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 3382.4 | Standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,3TBDMS,isomer #1 | CC(C)(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(=O)NCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | 3456.2 | Standard polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,3TBDMS,isomer #2 | CC(C)(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C(C)(C)C | 3534.4 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,3TBDMS,isomer #2 | CC(C)(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C(C)(C)C | 3438.7 | Standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,3TBDMS,isomer #2 | CC(C)(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C(C)(C)C | 3598.0 | Standard polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,3TBDMS,isomer #3 | CC(C)(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(O)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C(C)(C)C | 3545.3 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,3TBDMS,isomer #3 | CC(C)(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(O)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C(C)(C)C | 3423.2 | Standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,3TBDMS,isomer #3 | CC(C)(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(O)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C(C)(C)C | 3623.2 | Standard polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,4TBDMS,isomer #1 | CC(C)(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C(C)(C)C | 3702.3 | Semi standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,4TBDMS,isomer #1 | CC(C)(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C(C)(C)C | 3563.0 | Standard non polar | 33892256 |
| 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine,4TBDMS,isomer #1 | CC(C)(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(=O)N(CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C)[Si](C)(C)C(C)(C)C | 3437.9 | Standard polar | 33892256 |